000844223 001__ 844223
000844223 005__ 20210129232828.0
000844223 0247_ $$2doi$$a10.1007/s11060-018-2800-1
000844223 0247_ $$2ISSN$$a0167-594X
000844223 0247_ $$2ISSN$$a0167-594x
000844223 0247_ $$2ISSN$$a1573-7373
000844223 0247_ $$2pmid$$apmid:29464662
000844223 0247_ $$2WOS$$aWOS:000431890400012
000844223 0247_ $$2altmetric$$aaltmetric:33418824
000844223 037__ $$aFZJ-2018-01664
000844223 082__ $$a610
000844223 1001_ $$0P:(DE-HGF)0$$aSeibl-Leven, Matthias$$b0
000844223 245__ $$aClinical routine assessment of palliative care symptoms and concerns and caregiver burden in glioblastoma patients: an explorative field study
000844223 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V$$c2018
000844223 3367_ $$2DRIVER$$aarticle
000844223 3367_ $$2DataCite$$aOutput Types/Journal article
000844223 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1526980059_12328
000844223 3367_ $$2BibTeX$$aARTICLE
000844223 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000844223 3367_ $$00$$2EndNote$$aJournal Article
000844223 520__ $$aThe implementation of self-reported outcome measurements into clinical routine was tested to help facilitate early access to palliative care (PC) for glioblastoma (GBM)-patients. Measures detail PC symptoms and concerns and caregiver burden. Between January 2014 and December 2016, a total of 337 GBM-patients were discussed during meetings of the neuro-oncology tumor board to examine further treatment options. Each patient, along with their caregivers, was requested to participate in self-assessment using the palliative outcome scale (POS) and the Zarit Burden Interview (ZBI). Analyses encompassed summary statistics, non-parametric tests, visual graphic analysis, content analysis and assessing the utilization of the specialized PC consulting service (SPCCS). Ninety-five (28%) GBM-patients and 71 (21%) caregivers completed the self-assessment. Of these, 20 patients and 12 caregivers repeated the assessment at least once more during follow-up. POS total scores were similar in the group of patients with initial diagnosis [10 (0–31)] and those with later disease stages like recurrent diagnosis [9 (0–25)], but ZBI total scores differed [14 (0–51) vs. 24 (2–62)]. Single item analysis demonstrated that anxiety and worries about the future predominated. Caregivers were torn between high engagement in caring and feeling overburdened. Still, requests for the SPCCS showed no increase. Actual implementation of measures like POS and ZBI for detecting PC concerns and caregiver burden with GBM-patients in the field remains challenging as indicated by the limited response rate and lack of increased requests for the SPCCS. Modified clinical routines including strengthening awareness of PC, and allowing proxy-assessment might help to overcome barriers
000844223 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000844223 588__ $$aDataset connected to CrossRef
000844223 7001_ $$0P:(DE-HGF)0$$avon Reeken, Christian$$b1
000844223 7001_ $$0P:(DE-HGF)0$$aGoldbrunner, Roland$$b2
000844223 7001_ $$0P:(DE-HGF)0$$aGrau, Stefan$$b3
000844223 7001_ $$0P:(DE-HGF)0$$aRuge, Maximilian Ingolf$$b4
000844223 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b5
000844223 7001_ $$0P:(DE-Juel1)156211$$aDunkl, Veronika$$b6
000844223 7001_ $$0P:(DE-HGF)0$$aKocher, M.$$b7
000844223 7001_ $$0P:(DE-HGF)0$$aVoltz, Raymond$$b8
000844223 7001_ $$00000-0002-4403-630X$$aGolla, Heidrun$$b9$$eCorresponding author
000844223 773__ $$0PERI:(DE-600)2007293-4$$a10.1007/s11060-018-2800-1$$n2$$p321–333 $$tJournal of neuro-oncology$$v138$$x1573-7373$$y2018
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.pdf$$yRestricted
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.gif?subformat=icon$$xicon$$yRestricted
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.jpg?subformat=icon-180$$xicon-180$$yRestricted
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.jpg?subformat=icon-640$$xicon-640$$yRestricted
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.pdf?subformat=pdfa$$xpdfa$$yRestricted
000844223 8564_ $$uhttps://juser.fz-juelich.de/record/844223/files/10.1007_s11060-018-2800-1.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000844223 909CO $$ooai:juser.fz-juelich.de:844223$$pVDB
000844223 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b5$$kFZJ
000844223 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000844223 9141_ $$y2018
000844223 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000844223 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEURO-ONCOL : 2015
000844223 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000844223 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000844223 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000844223 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000844223 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000844223 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000844223 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000844223 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000844223 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000844223 920__ $$lyes
000844223 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000844223 980__ $$ajournal
000844223 980__ $$aVDB
000844223 980__ $$aI:(DE-Juel1)INM-3-20090406
000844223 980__ $$aUNRESTRICTED